UCLA Santa Monica Hematology Oncology /ID# 210551 — Los Angeles, California

UCLA Santa Monica Hematology Oncology /ID# 210551 is a clinical research site located in Los Angeles, California, United States 90095.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

UCLA Santa Monica Hematology Oncology /ID# 210551 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, Multiple Myeloma.

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA Santa Monica Hematology Oncology /ID# 210551?

UCLA Santa Monica Hematology Oncology /ID# 210551 has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA Santa Monica Hematology Oncology /ID# 210551 conducted?

UCLA Santa Monica Hematology Oncology /ID# 210551 has 1 clinical trials on record, with 1 currently active. Their work covers Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, Multiple Myeloma.

Is UCLA Santa Monica Hematology Oncology /ID# 210551 accredited by Crixeo Health?

UCLA Santa Monica Hematology Oncology /ID# 210551 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCLA Santa Monica Hematology Oncology /ID# 210551?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.